AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NEUREN PHARMACEUTICALS LTD

20.140

-0.210-1.03%

Volume:361.84K

Turnover:7.32M

Market Cap:2.55B

PE:129.17

High:20.650

Open:20.070

Low:19.900

Close:20.350

52wk High:23.588

52wk Low:10.920

Shares:126.64M

Float Shares:108.39M

Volume Ratio:1.07

T/O Rate:0.33%

Dividend:0.15

Dividend Rate:0.74%

EPS(TTM):0.156

EPS(LYR):0.233

ROE:6.17%

ROA:2.58%

PB:7.65

PE(LYR):86.55

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies-3.32%

Capital Flow

Inflow:

Outflow:

News

4DMedical And 2 Other Australian Growth Stocks To Own

Simply Wall St.

Neuren Says US Patent Allowance Could Extend Trofinetide Protection to 2041

MT Newswires Live

Elite Australian Growth Stocks To Own In September 2026

Simply Wall St.

Neuren Pharmaceuticals (ASX:NEU) Reports Higher Sales And Interim Dividend, Is The Valuation Too Rich?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/NEU.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NEU.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NEU.AU\",,,,,undefined,":{"symbol":"NEU.AU","market":"AU","secType":"STK","nameCN":"NEUREN PHARMACEUTICALS LTD","latestPrice":20.14,"timestamp":1790835120000,"preClose":20.35,"halted":0,"volume":361837,"delay":0,"changeRate":-0.01031941031941036,"nameEN":"NEUREN PHARMACEUTICALS LTD","floatShares":108394581,"shares":126639526,"eps":0.155917,"marketStatus":"Not Yet Opened","change":-0.21,"latestTime":"10-01 16:12:00 AEST","open":20.07,"high":20.65,"low":19.9,"amount":7322478,"amplitude":0.036855,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.155917,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1790899200000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":20.35,"dividendRate":0.007448,"openAndCloseTimeList":[[1790812800000,1790834400000]],"volumeRatio":1.0719971894166944,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"NEU.AU","preClose":20.14,"auctionPrice":20.27,"auctionVolume":458,"auctionTime":1790896098445,"referenceTime":1790850603090,"auction":1,"marketStatus":"盘前竞价","timestamp":1790896098445}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NEU.AU\",,,,,undefined,":{"symbol":"NEU.AU","floatShares":108394581,"roa":"2.58%","roe":"6.17%","lyrEps":0.2327,"volumeRatio":1.0719971894166944,"shares":126639526,"dividePrice":0.15,"high":20.65,"amplitude":0.036855,"preClose":20.35,"low":19.9,"week52Low":10.92,"pbRate":"7.65","psRate":"36.68","week52High":23.588,"institutionHeld":0,"latestPrice":20.14,"eps":0.155917,"divideRate":0.007448,"volume":361837,"delay":0,"ttmEps":0.155917,"open":20.07,"prevYearClose":18.475,"prevWeekClose":20.22,"prevMonthClose":20.35,"prevQuarterClose":20.35,"fiveDayClose":20.6,"twentyDayClose":20.421,"sixtyDayClose":16.658},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NEU.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-15","symbol":"NEU.AU","amount":0.15,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-16","defaultRemindTime":1789430400000,"name":"NEUREN PHARMACEUTICALS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-07","payableDate":"2026-09-16","currency":"AUD","dateTimestamp":1789394400000,"payDate":"2026-10-07"},{"date":"2026-08-26","symbol":"NEU.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787702400000,"name":null,"time":"","dateTimestamp":1787666400000,"actualEps":null},{"date":"2025-02-28","symbol":"NEU.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740697200000,"name":null,"time":"","dateTimestamp":1740661200000,"actualEps":null},{"market":"AU","date":"2024-02-29","symbol":"NEU.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1709125200000,"reportTimeType":"","actualEps":null},{"date":"2023-08-28","symbol":"NEU.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693180800000,"name":null,"time":"","dateTimestamp":1693144800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NEU.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2026-09-15","recordDate":"2026-09-16","paymentDate":"2026-10-07","value":0.15,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NEU.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671277550","title":"4DMedical And 2 Other Australian Growth Stocks To Own","url":"https://stock-news.laohu8.com/highlight/detail?id=2671277550","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671277550?lang=en_us&edition=fundamental","pubTime":"2026-09-30 07:21","pubTimestamp":1790724093,"startTime":"0","endTime":"0","summary":"Australia’s interest rate now sits at a 15 year high of 4.6%, which makes dependable earnings growth harder to find and more valuable when you do. Higher borrowing costs punish weak balance sheets, yet stronger businesses with solid finances and clear profit expansion stories can still build wealth. This article highlights three Australian high growth potential stocks from our healthy growth screen that fit that profile.\nThe three stocks covered below are a small sample, with the full healthy...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551730-choice1-card/1788960340613","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551730-choice1-card/1788960340613"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/4dmedical-and-2-other-australian-growth-stocks-to-own","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/4dmedical-and-2-other-australian-growth-stocks-to-own","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["JOYT","IIGF.AU","GXDW","ZYAU.AU","BK7043","DECU","GIVE.AU","BK7508","E200.AU","OZF.AU","RGLO","EIGA.AU","VAS.AU","BK7096","GEAR.AU","SLF.AU","IMLC.AU","VGFPF","4DX.AU","QRE.AU","DACE.AU","XKO.AU","IISV.AU","BBOZ.AU","VAP.AU","BK7503","IOZ.AU","BEAR.AU","PMDE","NEU.AU","XJO.AU","STW.AU","XAO.AU","VOTE","OZR.AU","MP1.AU","QFN.AU","BK7094","FEBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671261940","title":"Neuren Says US Patent Allowance Could Extend Trofinetide Protection to 2041","url":"https://stock-news.laohu8.com/highlight/detail?id=2671261940","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671261940?lang=en_us&edition=fundamental","pubTime":"2026-09-29 09:25","pubTimestamp":1790645148,"startTime":"0","endTime":"0","summary":"Neuren Pharmaceuticals  said partner Acadia Pharmaceuticals received a notice of allowance from the US Patent and Trademark Office for a new US patent covering weight-banded dosing of trofinetide, according to a Tuesday Australian bourse filing.The patent, once issued and with six months of pediatric exclusivity, is expected to extend US patent protection for trofinetide to March 28, 2041, nearly five years beyond the current protection period, the filing said.Trofinetide is marketed in the US under the brand names Daybue and Daybue Stix for patients aged two years and older with Rett syndrome, the filing added.The company's shares rose 2% in recent Tuesday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","USRD","NEU.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670707554","title":"Elite Australian Growth Stocks To Own In September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2670707554","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670707554?lang=en_us&edition=fundamental","pubTime":"2026-09-26 11:28","pubTimestamp":1790393289,"startTime":"0","endTime":"0","summary":"Rising long term bond yields have pushed borrowing costs higher, which puts pressure on many growth stocks that rely heavily on cheap debt. That makes financially healthier Australian growth stories more interesting right now. This screener focuses on businesses where analysts see strong earnings growth potential and balance sheets that can better handle higher rates. In this article, you will see three of the strongest candidates from that group.\nThe three Australian stocks highlighted below...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551730-choice1-card/1788960340613","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551730-choice1-card/1788960340613"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/elite-australian-growth-stocks-to-own-in-september-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/elite-australian-growth-stocks-to-own-in-september-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["4DX.AU","CHAT","QRE.AU","AIPO","ARTY","BBOZ.AU","EIGA.AU","BK7094","QTOC","IIGF.AU","IOZ.AU","BEAR.AU","ZYAU.AU","IMLC.AU","MP1.AU","AGIX","BK7096","OZR.AU","SLF.AU","XJO.AU","VTHR","XKO.AU","DACE.AU","IISV.AU","GEAR.AU","E200.AU","NEU.AU","OZF.AU","XAO.AU","GIVE.AU","BK7503","BK7508","QFN.AU","BK7043","VAS.AU","VAP.AU","STW.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664280868","title":"Neuren Pharmaceuticals (ASX:NEU) Reports Higher Sales And Interim Dividend, Is The Valuation Too Rich?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664280868","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664280868?lang=en_us&edition=fundamental","pubTime":"2026-09-02 00:27","pubTimestamp":1788280022,"startTime":"0","endTime":"0","summary":"Why Neuren Pharmaceuticals stock is in focus now\nNeuren Pharmaceuticals (ASX:NEU) has caught investor attention after reporting half year 2026 results showing higher sales and revenue, a lower net profit figure, and the declaration of a fully franked interim dividend.\nNeuren Pharmaceuticals shares trade at A$19.89, with a 90 day share price return of 46.36% and a 30 day share price return of 10.50%. This comes despite a 7 day share price pullback of 11.72%, while the 5 year total shareholder...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-neu/neuren-pharmaceuticals-shares/news/neuren-pharmaceuticals-asxneu-reports-higher-sales-and-inter","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-neu/neuren-pharmaceuticals-shares/news/neuren-pharmaceuticals-asxneu-reports-higher-sales-and-inter","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NEU","NEU.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":9,"pageCount":1,"totalSize":36,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NEU.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":-0.033237}]}}